首頁 > 市場調查報告書 > 製藥

生物保存市場規模、佔有率和成長分析（按產品、生物樣本、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898440

生物保存市場規模、佔有率和成長分析（按產品、生物樣本、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

Biopreservation Market Size, Share, and Growth Analysis, By Product (Biopreservation Media, Biopreservation Equipment), By Biospecimen (Human Tissue Samples, Organs), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球生物保存市場規模預計在 2024 年達到 35.9 億美元，從 2025 年的 46.1 億美元成長到 2033 年的 338.2 億美元，在預測期（2026-2033 年）內複合年成長率為 28.3%。

全球生物保存市場正經歷強勁成長，這主要得益於技術創新不斷改進生物材料（如DNA、組織和幹細胞）在不同條件下的保存方法。近期的一些創新，例如微陣列和預測建模的整合，簡化了生物保存流程，降低了時間和成本。多重細胞成像平台的興起進一步提升了生物保存的效能。該技術的應用範圍正在不斷擴大，涵蓋心臟病學和婦科等領域。慢性病的快速成長推動了生技藥品研發領域的需求，包括免疫療法和疫苗生產。此外，公私合作也促進了研究經費的增加。醫療保健成本的上升預計將推動人們對幹細胞保存和生物來源日益成長的興趣，進而推動市場成長。

全球生物防腐市場促進因素

全球慢性病發生率的上升趨勢正顯著推動全球生物製品保存市場的需求。在美國等已開發國家，超過30%的成年人患有慢性病，而在印度等開發中國家，這一比例也超過23%。慢性病的持續成長迫切需要有效的診斷和替代治療方案，從而增加了對生物製品保存策略的需求。醫療保健技術的進步以及生物製品保存在確保治療應用安全性和有效性以及維持生物製品活性方面的重要作用，進一步推動了這項需求的成長。因此，預計該市場將持續成長。

全球生物保存市場面臨的限制因素

全球生物保存市場面臨諸多限制因素，阻礙了其成長潛力。有效的生物保存依賴於對溫度、壓力、pH值以及其他物理因素的精確控制，這些因素需根據待保存生質能的特定穩定性進行調整。這需要先進的設備、專用耗材和培養基，而所有這些都需要熟練的人員才能有效操作。此外，許多耗材極不穩定或供應有限，進一步增加了生物保存過程的複雜性。建立必要基礎設施的高昂初始投資成本限制了生物保存技術在各個領域的廣泛應用，最終阻礙了市場擴張。

全球生物防腐市場趨勢

全球生物保存市場呈現強勁的上升趨勢，預計將以顯著的複合年成長率成長，這主要得益於細胞療法和基因工程需求的激增。這種成長促使生物醫藥公司加大研發投入。細胞和基因療法在診斷和治療嚴重病人及慢性疾病方面的巨大潛力正日益受到廣泛認可。此外，政府對基因療法和再生醫學研究中心的資助不斷增加，進一步推動了市場發展，凸顯了生物保存在現代醫療保健發展中日益成長的重要性。

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較
主要企業簡介
- 賽默飛世爾科技公司（美國）
- 默克集團（德國）
- BioLife Solutions, Inc.（美國）
- 幹細胞技術（加拿大）
- Helmer Scientific Inc.（美國）
- 普林斯頓低溫治療中心（美國）
- OPS Diagnostics（美國）
- ThermoGenesis Holdings, Inc.（美國）
- Avantor公司（美國）
- Bio-Techne公司（美國）
- 精確科學公司（美國）
- 沃辛頓工業公司（美國）
- Chart Industries, Inc.（美國）
- Azenta US, Inc.（美國）
- LabVantage Solutions, Inc.（美國）
- Qiagen NV（荷蘭）
- Taylor-Wharton Cryogenics LLC（美國）
- PHC控股株式會社（日本）
- 松下電器產業株式會社（日本）
- Lifeline Scientific, Inc.（美國）

結論與建議

簡介目錄

Product Code: SQMIG35I2223

Global Biopreservation Market size was valued at USD 3.59 Billion in 2024 and is poised to grow from USD 4.61 Billion in 2025 to USD 33.82 Billion by 2033, growing at a CAGR of 28.3% during the forecast period (2026-2033).

The Global Biopreservation Market is witnessing robust growth driven by technological advancements that enhance the preservation of biological materials, including DNA, tissues, and stem cells, under varied conditions. Recent innovations, such as microarrays and predictive modeling integration, have streamlined biopreservation processes, reducing time and costs. The rise of multiplex cellular imaging platforms further boosts biopreservation efficacy. This approach finds increased applications in specialties like cardiology and gynecology. The surging prevalence of chronic diseases fuels the demand for biological products, spanning immunotherapies and vaccine production, in R&D sectors. Additionally, collaboration between public and private entities is enhancing research funding. Growing interest in stem cell preservation and biologically derived medicines is poised to propel market growth, supported by rising healthcare expenditures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopreservation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biopreservation Market Segments Analysis

Global Biopreservation Market is segmented by Product, Biospecimen, Application, End User and region. Based on Product, the market is segmented into Biopreservation Media, Biopreservation Equipment and Biopreservation Accessories. Based on Biospecimen, the market is segmented into Human Tissue Samples, Organs, Stem Cells and Other Biospecimens. Based on Application, the market is segmented into Research Applications, Therapeutic Applications, Other Applications. Based on End User, the market is segmented into Biobanks, Gene Banks, Hospitals and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biopreservation Market

The increasing prevalence of chronic diseases worldwide significantly drives the demand for the global biopreservation market. In advanced economies like the United States, over 30% of adults are affected by such conditions, while developing nations, such as India, report figures exceeding 23%. The persistent rise in chronic diseases necessitates effective diagnosis and alternative treatment solutions, thereby amplifying the need for biopreservation strategies. This growing demand is further fueled by advancements in healthcare technologies and the crucial role biopreservation plays in maintaining the viability of biological products, ensuring their safety and efficacy in therapeutic applications. As such, the market is poised for continuous growth.

Restraints in the Global Biopreservation Market

The Global Biopreservation market faces several constraints that hinder its growth potential. Effective biopreservation relies on precise control of temperature, pressure, pH, and other physical factors tailored to the specific stability of the biomass being preserved. This necessitates sophisticated equipment, specialized consumables, and media solutions, all of which require skilled personnel to operate effectively. Additionally, many of these consumables are either highly unstable or have limited availability, further complicating the biopreservation process. The substantial initial investment costs associated with setting up the necessary infrastructure restrict the broader application of biopreservation techniques across various sectors, ultimately limiting market expansion.

Market Trends of the Global Biopreservation Market

The Global Biopreservation market is experiencing a robust upward trajectory, fueled by the surging demand for cell therapy and genetic engineering, with projections indicating a remarkable compound annual growth rate. This growth is prompting significant investments from biomedical companies aimed at advancing research and development initiatives. The transformative potential of cell and gene therapies in diagnosing and treating critical patients and chronic diseases is gaining widespread recognition. Additionally, increased government funding directed towards research centers specializing in gene therapy and regenerative treatments is further propelling the market forward, highlighting the escalating importance of biopreservation in modern healthcare advancements.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Technology Analysis

Global Biopreservation Market Size by Product & CAGR (2026-2033)

Market Overview
Biopreservation Media
- Cryopreservation Media
- Hypothermic Preservation Media
Biopreservation Equipment
- Temperature Control Systems
- Freezers
- Cryogenic Storage Systems
- Thawing Equipment
- Refrigerators
- Alarm Monitoring Systems
- Incubators
- Centrifuges
- Other Biopreservation Equipment
Biopreservation Accessories

Global Biopreservation Market Size by Biospecimen & CAGR (2026-2033)

Market Overview
Human Tissue Samples
Organs
Stem Cells
Other Biospecimens

Global Biopreservation Market Size by Application & CAGR (2026-2033)

Market Overview
Research Applications
Therapeutic Applications
Other Applications

Global Biopreservation Market Size by End User & CAGR (2026-2033)

Market Overview
Biobanks
Gene Banks
Hospitals
Other End Users

Global Biopreservation Market Size & CAGR (2026-2033)

North America (Product, Biospecimen, Application, End User)
- US
- Canada
Europe (Product, Biospecimen, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Biospecimen, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Biospecimen, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Biospecimen, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLife Solutions, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STEMCELL Technologies (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Helmer Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PrincetonCryo (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OPS Diagnostics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ThermoGenesis Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avantor, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Exact Sciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Worthington Industries, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chart Industries, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Azenta US, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LabVantage Solutions, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taylor-Wharton Cryogenics LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PHC Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Panasonic Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifeline Scientific, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments